Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD" Results 21 - 40 of 257
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Aug 2011, 5:18 am by Lawrence B. Ebert
The Mylan case is Teva Pharmaceuticals Industries Ltd. v. [read post]
13 Dec 2021, 6:50 am by Robert Kraft
The Pittsburgh Post-Gazette reports, “Teva Pharmaceutical Industries Ltd., one of the largest generic drugmakers in the world, has recalled more than 2.5 million vials of drugs that the company said may not be sterile. [read post]
26 Nov 2007, 9:02 pm
., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
1 Nov 2011, 6:30 am by Lawrence B. Ebert
The US Supreme Court denied cert in the Temodar case thus allowing Merck & Co. to block Teva Pharmaceutical Industries Ltd. from selling a generic form of the brain-cancer drug Temodar until 2013. [read post]
13 Oct 2014, 8:46 pm by Patent Docs
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00167; filed October 7, 2014 in the Northern District of West Virginia • Plaintiffs: Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Teva Neuroscience, Inc.; Yeda Research and Development Co., Ltd. [read post]
19 Jan 2009, 2:56 pm
Boston, Massachusetts– According to a January 5, 2009 report by Dow Jones Newswires, Teva Pharmaceutical Industries Ltd. [read post]
6 May 2010, 7:10 am by Carey, Danis & Lowe
Food and Drug Administration has issued a warning to Teva Pharmaceutical Industries Ltd.'s Parenteral Medicines unit about manufacturing problems that contaminated an anesthetic. [read post]
9 Feb 2007, 11:37 am
Singer In a February 9, 2007 press release, Sanofi-Aventis announced that it has lost its patent infringement suit against generic drugmakers Amphastar Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd., filed in the U.S. [read post]
15 Aug 2011, 7:32 am by Phil
(PFE) won a patent- infringement case that prevents Teva Pharmaceutical Industries Ltd. [read post]
The world’s largest manufacturer of generic pharmaceuticals, Israeli-based Teva Pharmaceutical Industries Ltd. [read post]
1 Dec 2011, 7:40 pm by Rantanen
By Jason Rantanen Teva Pharmaceutical Industries Ltd. v. [read post]
25 Aug 2016, 2:11 pm by Lawrence B. Ebert noted a PTAB ruling on some of Teva's Copaxone patents:Teva Pharmaceutical Industries Ltd. today [August 24, 2016] confirmed the Patent Trial and Appeal Board (PTAB) decisions from an Inter Partes Review (IPR) to invalidate all claims of the ‘250 and ‘413 patents for 40 mg COPAXONE® (glatiramer acetate injection). [read post]
9 Jan 2017, 9:36 am by Lawrence B. Ebert
In other words, Copaxone should remain a $4 billion drug, to Pantagraph: covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
12 Sep 2010, 9:55 pm by Patent Docs
Teva Pharmaceutical Industries Ltd. et al. 1:10-cv-00766; filed September 8, 2010 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Teva Pharmaceutical Industries Ltd.; Teva Pharamceuticals USA, Inc. [read post]
17 Mar 2013, 9:39 pm by Patent Docs
• Defendants: Teva Pharmaceutical Industries, Ltd.; Teva Pharmaceuticals USA, Inc. [read post]
2 Aug 2008, 3:27 am
By Sherri Oslick -- Earlier this week the litigation between Teva Pharmaceutical Industries Ltd. and Dr. [read post]
24 Apr 2016, 9:02 pm by Patent Docs
Biocon Ltd. et al. 1:16-cv-00278; filed April 19, 2015 in the District Court of Delaware • Plaintiffs: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd.; Teva Neuroscience Inc; Yeda Research and Development Co Ltd. [read post]
30 Jun 2009, 7:03 pm
Teva Pharmaceuticals USA, a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., is making a full-court press on getting the word out on the need for follow-on biologics. [read post]
5 Sep 2007, 6:17 am
Reuters reported on Sept. 5, 2007 that the CAFC upheld the validity of a key patent on Forest Laboratories' blockbuster depression drug Lexapro and confirmed a lower court's decision to block sales of generic forms of the drug made by Ivax (Teva Pharmaceutical Industries Ltd) and Cipla Ltd. [read post]